Literature DB >> 2013622

DNA flow cytometry of follicular non-Hodgkin's lymphoma.

J C Macartney1, R S Camplejohn, R Morris, K Hollowood, D Clarke, A Timothy.   

Abstract

S-phase fraction, an index of cellular proliferation, and DNA ploidy were measured by DNA flow cytometry in a retrospective study of lymph node biopsy specimens from 83 cases (before treatment) of follicular non-Hodgkin's lymphoma, Working Formulation categories B and C. The correlations between these measures and survival, clinical stage, symptoms and histopathological factors were investigated. Aneuploidy was rare (n = 16) and had no effect on length of survival or transformation to high grade lymphoma. The overall mean S-phase fraction was 3.6%; for the whole series increasing S-phase fraction was associated with decreased survival. A high S-phase fraction (more than 5%) in initial biopsy specimens was also associated with an increased risk of subsequent high grade transformation at relapse. There was no difference between the survival or proliferative activity of tumours composed of mainly small cleaved cells compared with those composed of mixed small and large cells. There was no difference in survival or proliferative activity between tumours showing a pure follicular growth pattern and those with a mixed follicular and diffuse growth pattern. Multifactorial analysis showed that an S-phase fraction of more than 5% and B symptoms were the most important factors determining survival in these follicular non-Hodgkin's lymphomas.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2013622      PMCID: PMC496940          DOI: 10.1136/jcp.44.3.215

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  24 in total

1.  Malignant lymphomas of follicular center cell origin in man. III. Prognostic features.

Authors:  R S Stein; J Cousar; J M Flexner; S E Graber; L C McKee; S Krantz; R C Collins
Journal:  Cancer       Date:  1979-12       Impact factor: 6.860

Review 2.  DNA flow cytometry of non-Hodgkin's lymphomas.

Authors:  J C Macartney; R S Camplejohn
Journal:  Eur J Cancer       Date:  1990       Impact factor: 9.162

3.  Sclerosis in non-Hodgkin's lymphomata.

Authors:  M H Bennett
Journal:  Br J Cancer Suppl       Date:  1975-03

4.  Nodular mixed lymphocytic-histiocytic lymphoma (NM): response and survival. Eastern Cooperative Oncology Group.

Authors:  E Z Ezdinli; W G Costello; F Icli; R E Lenhard; G J Johnson; M Silverstein; C W Berard; J M Bennett; P P Carbone
Journal:  Cancer       Date:  1980-01-15       Impact factor: 6.860

5.  Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry.

Authors:  D W Hedley; M L Friedlander; I W Taylor; C A Rugg; E A Musgrove
Journal:  J Histochem Cytochem       Date:  1983-11       Impact factor: 2.479

6.  Prognostic factors in nodular lymphomas: a multivariate analysis based on the Princess Margaret Hospital experience.

Authors:  M K Gospodarowicz; R S Bush; T C Brown; T Chua
Journal:  Int J Radiat Oncol Biol Phys       Date:  1984-04       Impact factor: 7.038

7.  Analysis of non-Hodgkin's lymphomas with nodular and favorable histologies, stages I and II.

Authors:  S B Paryani; R T Hoppe; R S Cox; T V Colby; S A Rosenberg; H S Kaplan
Journal:  Cancer       Date:  1983-12-15       Impact factor: 6.860

8.  The pattern of cell growth in reticulum cell sarcoma and lymphosarcoma.

Authors:  M J Peckham; E H Cooper
Journal:  Eur J Cancer       Date:  1970-10       Impact factor: 9.162

9.  Labeling index as a prognostic marker in non-Hodgkin's lymphomas.

Authors:  A Costa; G Bonadonna; E Villa; P Valagussa; R Silvestrini
Journal:  J Natl Cancer Inst       Date:  1981-01       Impact factor: 13.506

10.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640

View more
  5 in total

Review 1.  Clinical and molecular prognostic factors in follicular lymphoma.

Authors:  Andrew J Davies
Journal:  Curr Oncol Rep       Date:  2006-09       Impact factor: 5.075

2.  Correlations between apoptotic and proliferative indices in malignant non-Hodgkin's lymphomas.

Authors:  L Leoncini; M T Del Vecchio; T Megha; P Barbini; P Galieni; S Pileri; E Sabattini; F Gherlinzoni; P Tosi; R Kraft
Journal:  Am J Pathol       Date:  1993-03       Impact factor: 4.307

3.  Nucleolar organiser regions and survival in patients with non-Hodgkin's lymphomas classified by the working formulation.

Authors:  J Jakić-Razumović; D Tentor; M Petrovecki; I Radman
Journal:  J Clin Pathol       Date:  1993-10       Impact factor: 3.411

4.  Tumour cell proliferation, but not apoptosis, predicts survival in B-cell non-Hodgkin's lymphomas.

Authors:  T Stokke; E B Smeland; S Kvaløy; H Holte
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

5.  Proliferation and apoptosis in malignant and normal cells in B-cell non-Hodgkin's lymphomas.

Authors:  T Stokke; H Holte; L Smedshammer; E B Smeland; O Kaalhus; H B Steen
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.